Title : XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population.

Pub. Date : 2008 Oct

PMID : 18400332






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population. Cisplatin X-ray repair cross complementing 1 Homo sapiens
2 The predictability of DNA repair XRCC1 (X-ray repair cross-complementing group 1 protein) single nucleotide polymorphisms (SNPs) for cisplatin-based grades 3 and 4 chemotherapy-related toxicity in patients with newly diagnosed advanced lung cancer was evaluated. Cisplatin X-ray repair cross complementing 1 Homo sapiens
3 The predictability of DNA repair XRCC1 (X-ray repair cross-complementing group 1 protein) single nucleotide polymorphisms (SNPs) for cisplatin-based grades 3 and 4 chemotherapy-related toxicity in patients with newly diagnosed advanced lung cancer was evaluated. Cisplatin X-ray repair cross complementing 1 Homo sapiens
4 Our results suggested that patients carrying at least one variant XRCC1 Arg399Gln allele have a 2.5-fold increased risk of grade 3 or 4 gastrointestinal toxicity when treated with first-line cisplatin-based chemotherapy. Cisplatin X-ray repair cross complementing 1 Homo sapiens